Trial Profile
Double-blind, Cross-over, Placebo Controlled Pilot Study to Characterize the Profile of Those Patients With Traumatic Spinal Cord Injury Diagnosed by Electrophysiological, Urodynamic and Clinical (ASIA Group) Assessment Who May Respond to Vardenafil
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 11 Apr 2022
Price :
$35
*
At a glance
- Drugs Vardenafil (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- Acronyms LEMDE
- Sponsors Bayer
- 07 Apr 2022 This trial has been completed in Spain (Global end date: 13/02/2007), according to European Clinical Trials Database record.
- 20 May 2008 New trial record.